Bettina Scheibe

Bettina Scheibe is a Munich-based solo angel writing $25K to $100K at pre-seed and seed into AI/ML in healthcare and biotech. The explicit AI focus combined with biotech is differentiating in the German angel landscape, where most healthcare investors index on devices, traditional biotech, or digital health rather than AI-led clinical and life sciences platforms. Public data is limited to a LinkedIn profile, so founders should expect a relationship-driven angel rather than an institutional vehicle. The Munich base places her in Germany’s largest biotech and life sciences hub, with proximity to TUM, Helmholtz Munich, the Martinsried biotech cluster, and the broader Bavarian medtech and pharma ecosystem. Check size positions her as a single-conviction angel suited to syndicate participation rather than a round leader, with highest value to European founders who want a Munich-based AI-and-biotech-credentialed angel for clinical, scientific, and regional network access. Founders most likely to fit are early TechBio teams combining AI with wet-lab biology, AI-driven biotech platforms, clinical AI software with a German or European go-to-market, and any team that benefits from Munich-region biotech network introductions. US-only founders, devices, consumer wellness, and pure non-AI health IT are weaker matches. The entry path is a LinkedIn message, preferably warmed by a mutual German biotech or AI healthcare connection, leading with the science and AI moat, the team’s credentials, and the specific Munich-region scientific and commercial relationships that her network materially provides at pre-seed and seed.